Fady Ibraham Malik - Apr 13, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: EVP Research & Development
Signature: /s/ John Faurescu, attorney-in-fact for Dr. Malik
Stock symbol: CYTK
Transactions as of: Apr 13, 2023
Transactions value $: -$136,840
Form type: 4
Date filed: 4/13/2023, 04:49 PM
Previous filing: Mar 9, 2023
Next filing: May 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Sale	-$137K	-4K	-2.34%	$34.21	167K	Apr 13, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.